David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
Among the biggest winners in Monday’s early trading are Bristol-Myers Squibb (NYSE: BMY), MedcoHealth (NYSE: MHS) and Goodrich Petroleum (NYSE: GDP). Top Percentage Gainers — Monday, June 7, 2010 Company Name (Ticker) Intra-Day Price Intra-Day % Gain 52-Week High… Read More
Among the biggest losers in Monday’s early trading are Delcath (NYSE: DCTH), CVS Caremark (NYSE: CVS) and Coldwater Creek (Nasdaq: CWTR). Top Percentage Losers — Monday, June 7, 2010 Company Name (Ticker) Intra-Day Price Intra-Day % Loss 52-Week High 52-Week Low Delcath (Nasdaq: DCTH) $12.80 -12.6% $16.45 $2.71… Read More
How many times has this happened to you lately? You carefully research and buy a stock. The company announces unexpectedly good financial results. But the stock’s price plummets, caught up in one of the market’s now-frequent downdrafts. You curse high-frequency traders. Your sleep suffers as the market… Read More
What a week. The market gyrations are likely triggering strong demand for heartburn medicine right now. Stocks of all stripes took it on the chin, and many are now down for the year. Whiles investors focused on the daunting headlines, they may have overlooked some important news coming out of… Read More
In investing, boring can be beautiful. Many investors like to chase stocks with hot new products from the likes of Apple (Nasdaq: AAPL) and Google (Nasdaq: GOOG), with the tradeoff being that emotions can create volatile stock prices as greed and fear play as much a part as underlying business… Read More
Investors tend to buy stocks when the market is on the upswing and avoid them when the market is flashing red. But if you focus simply on value, then you should be buying at lows. And right now, a whole host of stocks are trading at lows for the year,… Read More
Here’s the most important number you need to know today: $8 billion. That’s the amount of cash that BP (NYSE: BP) is likely to generate, year-in and year-out, assuming energy prices stay where they are right now. And that number should be kept in mind as investors tally up all… Read More
Rome wasn’t built in a day. That refrain is often employed when management embarks on a turnaround. The problem, though, is that investors may begin to lose their confidence. If they’re forced to wait too long, they may lose hope, sell out and force… Read More
Among the biggest winners in Friday’s early trading are Martek Biosciences (Nasdaq: MATK), Quiksilver (NYSE: ZQK) and Krispy Kreme (NYSE: KKD). Top Percentage Gainers — Friday, June 4, 2010 Company Name (Ticker) Intra-Day Price Intra-Day % Gain 52-Week High 52-Week Low Martek Biosciences (Nasdaq: MATK) $22.39 +16.3%… Read More
Among the biggest losers in Friday’s early trading are Blyth (NYSE: BTH), athenahealth (Nasdaq: ATHN) and Banco Bilbao Vizcaya (NYSE: BBVA). Top Percentage Losers — Friday, June 4, 2010 Company Name (Ticker) Intra-Day Price Intra-Day % Loss 52-Week High 52-Week Low Blyth (NYSE: BTH) $40.96 -17.5% $59.93 $25.91… Read More
